Article
Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease.
Frontiers in immunology - 1 Jan 2020
Spilleboudt Chloé, De Wilde Virginie, Lewalle Philippe, Cabanne Ludovic, Leclerc Mathieu, Beckerich Florence, Bories Dominique, Cardoso Silvia, Soares Miguel P, Vokaer Benoît, Hougardy Jean-Michel, Flamand Véronique, Racapé Judith, Abramowicz Marc, Maury Sébastien, Le Moine Alain
Abstract excerpt
Graft-versus-host disease (GVHD) remains a major clinical drawback of allogeneic hematopoietic stem cell transplantation (HSCT). Here, we investigated how the stress responsive heme catabolizing enzyme heme oxygenase-1 (HO-1, encoded by HMOX1) regulates GVHD in response to allogeneic hematopoietic stem cell transplantation in mice and humans. We found that deletion of the Hmox1 allele, specifically in the myeloid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
